Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Markowitz

Showing results (51-60 of 604) with videos related to

Pageof 61
Sort By:
Therapeutic Drug Monitoring|April 1, 1997
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populationsJ S Markowitz, C L Devine
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 1, 1996
Zolpidem-induced psychosisJ S Markowitz, T D Brewerton
Planta Medica|January 25, 2017
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)Ahmed A Albassam, John S Markowitz
Kidney International|January 15, 2017
New insights into the pathogenesis and treatment of heavy chain deposition diseaseJonathan J Hogan, Glen S Markowitz
European Journal of Clinical Pharmacology|August 1, 2012
Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activationHao-Jie Zhu, John S Markowitz
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Drug-induced renal failure: a focus on tubulointerstitial diseaseGlen S Markowitz, Mark A Perazella
Kidney International|February 1, 2007
The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 yearsG S Markowitz, V D D'Agati
Journal of Child and Adolescent Psychopharmacology|September 15, 2017
The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity DisorderJohn S Markowitz, Kennerly S Patrick
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2016
Lupus Podocytopathy: A Distinct EntityAndrew S Bomback, Glen S Markowitz
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Pageof 61

Showing results (51-60 of 604) with videos related to

Sort By:
Pageof 61
Therapeutic Drug Monitoring|April 1, 1997
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populationsJ S Markowitz, C L Devine
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 1, 1996
Zolpidem-induced psychosisJ S Markowitz, T D Brewerton
Planta Medica|January 25, 2017
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)Ahmed A Albassam, John S Markowitz
Kidney International|January 15, 2017
New insights into the pathogenesis and treatment of heavy chain deposition diseaseJonathan J Hogan, Glen S Markowitz
European Journal of Clinical Pharmacology|August 1, 2012
Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activationHao-Jie Zhu, John S Markowitz
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Drug-induced renal failure: a focus on tubulointerstitial diseaseGlen S Markowitz, Mark A Perazella
Kidney International|February 1, 2007
The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 yearsG S Markowitz, V D D'Agati
Journal of Child and Adolescent Psychopharmacology|September 15, 2017
The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity DisorderJohn S Markowitz, Kennerly S Patrick
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2016
Lupus Podocytopathy: A Distinct EntityAndrew S Bomback, Glen S Markowitz
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Pageof 61